| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/29/2006 | CA2591117A1 Novel heteroarylacetamides |
| 06/29/2006 | CA2589773A1 Pyridine carboxamide derivatives for use as anticancer agents |
| 06/29/2006 | CA2589764A1 Amide derivatives |
| 06/29/2006 | CA2589748A1 Heterocyclic compounds as ccr2b antagonists |
| 06/29/2006 | CA2589331A1 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 06/29/2006 | CA2588028A1 Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists |
| 06/29/2006 | CA2587664A1 Compounds with kv4 ion channel activity |
| 06/28/2006 | EP1674464A1 Novel thrombin inhibitors |
| 06/28/2006 | EP1674463A1 Rabeprazole sodium salt in crystalline hydrate form |
| 06/28/2006 | EP1674457A1 Derivatives of squaric acid with anti-proliferative activity |
| 06/28/2006 | EP1674100A1 Angiogenesis inhibitor |
| 06/28/2006 | EP1674097A1 Compounds effecting glucokinase |
| 06/28/2006 | EP1673369A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 06/28/2006 | EP1673367A1 Fused lactam compounds |
| 06/28/2006 | EP1673366A1 1-"2-(4-hydroxyphenyl)-2-hydroxyethyl]-piperidin-4-ol compounds as nmda receptor antagonists |
| 06/28/2006 | EP1673357A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 06/28/2006 | EP1673355A1 Substituted triazole derivatives as oxytocin antagonists |
| 06/28/2006 | EP1673354A1 Arylindenopyridines and arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| 06/28/2006 | EP1673353A1 Transition state structure and inhibitors of thymidine phosphorylases |
| 06/28/2006 | EP1673350A2 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 06/28/2006 | EP1673349A1 Benzimidazole derivates: preparation and pharmaceutical applications |
| 06/28/2006 | EP1673348A2 Benzoimidazole compounds |
| 06/28/2006 | EP1673345A1 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation |
| 06/28/2006 | EP1673342A2 Amides that inhibit vanilloid receprot subtype 1 (vr1) receptor |
| 06/28/2006 | EP1673087A2 Alkoxy substituted imidazoquinolines |
| 06/28/2006 | EP1673086A1 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors |
| 06/28/2006 | EP1673085A2 C-met modulators and methods of use |
| 06/28/2006 | EP1673081A1 Indoles and azaindoles as antiviral agents |
| 06/28/2006 | EP1395261B1 Pyridylpyrimidine derivatives as effective compounds against prion diseases |
| 06/28/2006 | CN1795193A N-acyl nitrogen heterocyles as ligands of peroxisome proliferator-activated receptors |
| 06/28/2006 | CN1795191A 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them |
| 06/28/2006 | CN1795186A Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5 |
| 06/28/2006 | CN1795185A Process for making substituted pyrazoles |
| 06/28/2006 | CN1795184A Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5 |
| 06/28/2006 | CN1795179A Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 06/28/2006 | CN1795177A 1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 06/28/2006 | CN1795175A Acetylene derivatives as inhibitors of histone deacetylase |
| 06/28/2006 | CN1795174A Novel substituted 3-sulfur indoles |
| 06/28/2006 | CN1794990A Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 06/28/2006 | CN1793138A Process for prepering aspetllinone |
| 06/28/2006 | CN1261430C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 06/28/2006 | CN1261099C Tetrahydroquinoline derivatives |
| 06/28/2006 | CN1261098C p38-alpha kinase inhibitors |
| 06/27/2006 | US7067672 metallating a nicotine derivative with a metal base complex to form an organometallic intermediate, which is reacted with a halogenating agent, especially I2, C2Cl6, N-bromosuccinimide, Br2, N-iodosuccinimide, CCl4, or 1,3-dichloro-5,5-dimethylhydantoin. |
| 06/27/2006 | US7067671 Useful in treatment of a variety of cytokine related disorders including rheumatoid arthritis, inflammatory bowel disease, septic shock, osteoporosis, osteoarthritis, neuropathic pain, HIV replication, HIV dementia |
| 06/27/2006 | US7067670 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 06/27/2006 | US7067669 combining 6-hydroxy-3,4-dihydroquinolinone and an alkali metal carbonate; removing water using molecular sieves; adding 1-cyclohexyl-5-(4-halobutyl)-tetrazole; and recovering cilostazol. |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067662 CXCR3 antagonists |
| 06/27/2006 | US7067660 Process for the preparation of pyrazolopyrimidinones |
| 06/27/2006 | US7067656 Sulfamoyl compounds and agricultural and horticultural fungicides |
| 06/27/2006 | US7067655 Adenosine A2a receptor antagonists |
| 06/27/2006 | US7067551 Deacetylase inhibitors |
| 06/27/2006 | US7067549 Pyrrolidone carboxamides |
| 06/27/2006 | US7067548 Non-emetic 1-phenyl- or pyridyl-pyrazoles. |
| 06/27/2006 | US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 06/27/2006 | US7067536 phosphodiesterase 4 inhibitors in immunocompetent cells, such as macrophages and lymphocytes; side effect reduction; N-(3,5-dichloro-1-oxopyridin-4-yl)-[7-hydroxy-1-(3- or 2-nitrobenzyl)-indol-3-yl]glyoxylamide |
| 06/27/2006 | US7067534 Melanin-concentrating hormone; N-(N'-substituted indolyl)methyl-4-(m-alkylamidophenyl) piperidine; antidepressants, anxiolytic agents; obesity, incontinence |
| 06/27/2006 | US7067532 Substituted quinolines as antitumor agents |
| 06/27/2006 | US7067531 Quinolinone derivatives containing imidazole rings is useful as anticarcinogenic agent |
| 06/27/2006 | US7067529 a 1-benzoyl-6- or 7-methoxy-isoquinoline; antidiabetic agents; Type II diabetes |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067522 anticarcinogenic, antitumor, antiproliferative agents; focal adhesion kinase (FAK) and cyclin-dependent kinase (CDK) enzyme inhibitors |
| 06/27/2006 | US7067518 Pyridinyl-methyl-ethyl cyclohexanecarboxamides as serotonergic agents |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
| 06/27/2006 | US7067514 Pyrimidine compounds |
| 06/27/2006 | US7067513 Phenylpiperazines |
| 06/27/2006 | US7067512 Substituted 1,4-benzodiazepines and uses thereof |
| 06/27/2006 | US7067506 Compounds useful for inhibiting Chk1 |
| 06/27/2006 | US7067305 Enzymatic process for the resolution for enantiomeric mixtures of β-lactams |
| 06/27/2006 | CA2238633C Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
| 06/22/2006 | WO2006066197A1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 06/22/2006 | WO2006065946A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases |
| 06/22/2006 | WO2006065872A1 Piperazinyl-pyridine analogues |
| 06/22/2006 | WO2006065794A1 Farnesyl protein transferase inhibitors and methods for treating proliferative diseases |
| 06/22/2006 | WO2006065686A2 Spiro derivatives as lipoxygenase inhibitors |
| 06/22/2006 | WO2006065590A2 Pyridine and pyrimidine antiviral compositions |
| 06/22/2006 | WO2006065480A2 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 06/22/2006 | WO2006065479A2 Substituted phenols as active agents inhibiting vegf production |
| 06/22/2006 | WO2006065277A2 Heterocyclic aspartyl protease inhibitors |
| 06/22/2006 | WO2006065216A1 Novel hydantoin derivatives as metalloproteinase inhibitors |
| 06/22/2006 | WO2006065215A1 Novel compounds |
| 06/22/2006 | WO2006064944A1 Substituted pyrrole derivative |
| 06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | WO2006064375A2 Aminoaryl substituted five-membered ring heterocyclic compounds for the treatment of diseases |
| 06/22/2006 | WO2006064351A2 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 06/22/2006 | WO2006064249A2 Process for the preparation of pantoprazole sodium |
| 06/22/2006 | WO2006064218A1 Hydantoin derivatives useful as metalloproteinase inhibitors |
| 06/22/2006 | WO2006064044A1 Indolinones and their use as antiproliferative agents |
| 06/22/2006 | WO2006063866A1 Unsymmetrical diazo compounds, compositions comprising same, dyeing method and device comprising said compositions |
| 06/22/2006 | WO2006063812A1 3-cycloalkyl-1,2,4-triazin-5(2h)-ones |
| 06/22/2006 | WO2006063811A2 Substituted 1,2,4-triazin-5(2h)-ones |
| 06/22/2006 | WO2006063791A1 3-benzylthio-1,2,4-triazine-5 (2h)-one as paf-ah inhibitors |
| 06/22/2006 | WO2006063763A1 Pyrrole derivatives having crth2 receptor antagonist activity |
| 06/22/2006 | WO2006063466A1 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors |
| 06/22/2006 | WO2006048761A3 Methods for preparing indazole compounds |
| 06/22/2006 | WO2006042034A3 Salt and crystalline forms thereof of a drug |
| 06/22/2006 | WO2006028904A9 Quinazolines useful as modulators of ion channels |
| 06/22/2006 | WO2006024741A3 Hybrid qa molecules wherein q is an aminoquinoline and a is an antibiotic residue, their synthesis and their uses as antibacterial agent |